Clinical Study on Flumatinib Mesylate Combined with Chemotherapy Followed by Autologous Hematopoietic Cell Transplantation in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
Journal Title: Diseases & Research - Year 2023, Vol 3, Issue 1
Abstract
Objective To investigate the clinical efficacy and safety of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) patients treated with second-generation tyrosine kinase inhibitor (TKI) flumatinib mesylate combined with chemotherapy followed by autologous hematopoietic stem cell transplantation(auto-HSCT). Methods From September 2020 to March 2022, clinical informations of Ph+ALL patients who received flumatinib mesylate, chemotherapy and auto-HSCT were collected and analyzed. Results Of the 8 patients who were enrolled, a median age was 43 years old. The BCR-ABL transcript type was P190 in patients with the exception of one P210. It was determined that 2 patients suffered from tuberculosis (TB), and 1 patient developed central nervous system leukemia (CNSL). All patients got clinical remissions after the chemotherapy. A total of 4 patients (50%) received auto-HSCT in major molecular response (MMR). However, 1 patient (12.5%) relapsed following auto-HSCT and was switched to dasatinib therapy. Flumatinib was used during the induction and consolidation chemotherapy except the period of HSCT. Myelosuppression and infection were the most common side effects. At a median follow-up of 19.22 months, the 1-year OS rate was 75%. Conclusion Flumatinib combined with chemotherapy followed by auto-HSCT in Ph+ALL achieved a great remission rate and safety.
Authors and Affiliations
Shaojuan Cui, Xiaoyan Tan, Jianchuan Deng, Qing Yang, Jia Yao, Nan Zhang, Yan Shen
Keywords
Related Articles
- EP ID EP740138
- DOI 10.54457/DR.202301002
- Views 52
- Downloads 2
Effect of Comparison between Qingchangligan Granules and Qingchangligan Decoction on D-GalN/LPS-Induced Liver Injury in Mice
Ethnopharmacological relevance The Qingchangligan formula has two dosage forms, granules and decoction. Both of them have the same prescription; however, whether their protective effects are different remain elusive. Ai...
Roles of Toll-like Receptor 3 in Intrauterine Transmission of Hepatitis B Virus in Mothers with High Viral Load
Backgrounds Despite passive and active immunization, perinatal mother-to-infant transmission (MTIT) of hepatitis B virus (HBV) still occurs in women with high levels of viremia. Thus, understanding the mechanisms of MTIT...
A Commentary on the Natural Disease Progression Sequence of Chronic Hepatitis B
Hepatitis B virus (HBV), an ancient family of hepatotropic DNA viruses with origins dating back millions of years, remains a major burden to human health today, although hepatitis B vaccines have dramatically reduced the...
Liquid Biopsies: As an Emerging Tool in Cancer Diagnosis and Monitoring Therapies in Metastasis
Despite the availability of advanced diagnosis and treatment methods, cancer is still a leading cause of morbidity. The most readily and routinely available method for cancer diagnosis is tissue biopsy. Tissue biopsies a...
Successful Treatment with CAR- T Cells in a Patient with Immune Thrombocytopenia Associated with Castleman Disease
Multicentric Castleman disease (MCD), a rare lymphoproliferative disorder of incompletely understood etiology, is manifested as enlarged multiple lymph node and multiple organs involvement. The best therapeutic option fo...